Egypt’s National Medicines Policy Built on 10 Pillars to Ensure Treatment Availability

The Egyptian Drug Authority has said the national medicines policy rests on 10 core, interconnected pillars aimed at ensuring the availability of treatment.

The policy seeks to build a pharmaceutical system that is more efficient, sustainable and resilient, according to the authority.

The authority described the pillars as complementary components of a single framework, linking access to medicines with the longer-term strength of the pharmaceutical system.

Its statement outlined the policy’s broad objectives but did not detail the individual pillars or provide a timetable for implementation.